PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report

CONCLUSION: The detection of PIK3CA mutation in TNBC after neoadjuvant treatment might be associated with early relapse or rapid disease progression.PMID:34513603 | PMC:PMC8394163 | DOI:10.5306/wjco.v12.i8.702

Source: Clinical Breast Cancer - September 13, 2021 Category: Cancer & Oncology Authors: Guillermo Arturo Valencia Patricia Rioja Zaida Morante Jhajaira M Araujo Heberth Daniel Vallejos Henry Guerra Henry L Gomez Source Type: research